Brugada综合征与右室流出道传导储备减少:最终共同通路?
本文综述Brugada综合征(BrS)的病理生理机制,探讨其是通道病还是心肌病、复极还是除极异常。文章提出BrS的最终共同通路可视为「右室流出道传导储备减少」的疾病。
要点
- BrS最初被描述为原发性电疾病,以右胸导联ST抬高为特征。
- 早期发现右室结构异常和右室流出道(RVOT)传导延迟引发机制争议。
- 综述提出BrS最终共同通路为「RVOT传导储备减少」。
核心结论
- BrS的最终共同通路可视为「右室流出道传导储备减少」的疾病。
研究设计与样本
- 综述,探讨BrS的病理生理、遗传与非遗传基础及临床意义。
主要发现
- BrS早期被描述为原发性电疾病,以右胸导联ST抬高为特征。
- BrS患者存在右室结构异常和RVOT传导延迟的早期描述。
- 当前争议在于BrS是通道病还是心肌病、复极还是除极异常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brugada syndrome (BrS) was first described as a primary electrical disorder predisposing to the risk of sudden cardiac death and characterized by right precordial lead ST elevation. Early description of right ventricular structural abnormalities and of right ventricular outflow tract (RVOT) conduction delay in BrS patients set the stage for the current controversy over the pathophysiology underlying the syndrome: channelopathy or cardiomyopathy; repolarization or depolarization. This review examines the current understanding of the BrS substrate, its genetic and non-genetic basis, theories of pathophysiology, and the clinical implications thereof. We propose that the final common pathway for BrS could be viewed as a disease of 'reduced RVOT conduction reserve'.
引用
- Behr ER, Ben-Haim Y, Ackerman MJ, et al. Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway? Eur Heart J. 2021. PMID: 33421051. doi:10.1093/eurheartj/ehaa1051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。